Stay informed with the latest updates for the inheritable blood disorders community.

          Industry
          New Inhibitor Screening Kit Unveiled at THSNA
          Catalyst Begins Phase 2/3 Trial of Investigational Subcutaneous Therapy
          Medical
          Current and Emerging Therapies the Focus of New Medscape Activity
          Current and Emerging Therapies the Focus of New Medscape Activity
          Medical
          New Medscape Activity Reviews Current and Emerging Treatments for Hemophilia A
          New Medscape Activity Reviews Current and Emerging Treatments for…
          Industry
          Sangamo Announces First Patient Treated in Hemophilia B Gene Therapy Trial
          BioMarin Reports Positive Gene Therapy Trial Data at ASH
          Industry
          Pfizer Initiates First Stage of Phase 3 Hemophilia B Gene Therapy Trial
          Alnylam Announces FDA Lift of Hold on Fitusiran Trials
          Industry
          Shire and Rani Agree to Collaborate on Development of Orally-Administered Hemophilia A Therapy
          Shire and Rani Agree to Collaborate on Development of…
          Industry
          Spark Reports Positive Clinical Trial Data on Hemophilia A and B Gene Therapies at ASH
          Spark Reports Positive Clinical Trial Data on Hemophilia A and…
          NHF Supports Senate Bill to Stop Spread of Short-Term Plans
          NHF Healthcare Update: Congressional To-Do List
          Industry
          Genentech Announces Positive HEMLIBRA Trial Results
          HEMLIBRA® Shows Prophylactic Efficacy in Hemophilia A Patients…
          NBDF & Community
          NHF Announces the 2017 NHF/Novo Nordisk Career Development Award Recipient
          NHF Announces the 2017 NHF/Novo Nordisk Career Development Award Recipient…
          Advocacy & Legislative
          It's Not Too Late: Take Action on Tax Reform
          It's Not Too Late: Take Action on Tax Reform
          Medical
          Partners Module Addresses Psychosocial Considerations in Children with Hemophilia
          Partners Module Addresses Psychosocial Considerations in Children…
          NBDF & Community
          "Action to Hope" Study Open to Hemophilia Community
          "Action to Hope" Study Open to Hemophilia Community
          NBDF & Community
          Clinician Monographs Available through NHF Resource Center
          Clinician Monographs Available through NHF Resource Center
          Industry
          FDA Grants Orphan Drug Designation for Rofecoxib, Pain Medication for Hemophilia Arthropathy
          FDA Grants Orphan Drug Designation for Rofecoxib, Pain…